Hexosylceramides and glycerophosphatidylcholine GPC(36:1) increase in Multi-Organ Dysfunction Syndrome patients with Pediatric Intensive Care Unit Admission over 8-day hospitalization

Mara L. Leimanis-Laurens, Emily Wolfrum, Karen Ferguson, Jocelyn R. Grunwell, Dominic Sanfilippo, Jeremy W Prokop, Todd A. Lydic, Surender Rajasekaran
doi: https://doi.org/10.1101/2021.02.11.21251596

Article usage

Article usage: February 2021 to August 2025

AbstractFullPdf
Feb 2021256253
Mar 20214571055
Apr 2021229120
May 202177421
Jun 202162211
Jul 20213239
Aug 20212173
Sep 20212569
Oct 20212834
Nov 202134411
Dec 20211828
Jan 20222665
Feb 20221638
Mar 20221606
Apr 20222214
May 20221915
Jun 202226171
Jul 202218055
Aug 20222234
Sep 20222706
Oct 20222105
Nov 20221122
Dec 20221113
Jan 20231301
Feb 20231233
Mar 2023815
Apr 20231816
May 20231013
Jun 2023940
Jul 2023623
Aug 202318127
Sep 20231341
Oct 20231002
Nov 202323101
Dec 2023911
Jan 20241202
Feb 20241321
Mar 2024937
Apr 2024638
May 2024302
Jun 20242145
Jul 2024804
Aug 2024514
Sep 20242537
Oct 2024732
Nov 2024705
Dec 2024616
Jan 20256113
Feb 20253298
Mar 2025203012
Apr 202514011
May 202510618
Jun 20251657
Jul 2025191216
Aug 2025101
Back to top
Posted February 18, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Hexosylceramides and glycerophosphatidylcholine GPC(36:1) increase in Multi-Organ Dysfunction Syndrome patients with Pediatric Intensive Care Unit Admission over 8-day hospitalization
Mara L. Leimanis-Laurens, Emily Wolfrum, Karen Ferguson, Jocelyn R. Grunwell, Dominic Sanfilippo, Jeremy W Prokop, Todd A. Lydic, Surender Rajasekaran
medRxiv 2021.02.11.21251596; doi: https://doi.org/10.1101/2021.02.11.21251596
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area